ArticleExperimental and therapeutic medicine2020

TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents.

Hao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.